美国退伍军人初次全膝关节置换术中抗生素骨水泥使用与翻修风险
该回顾性研究纳入2007至2015年美国退伍军人健康管理局医院使用Palacos骨水泥行初次全膝关节置换术且随访至少2年的患者,比较含抗生素骨水泥与普通骨水泥的翻修率。含抗生素骨水泥使用率从2007年50.6%升至2015年69.4%,平均随访5年时与较低的全因翻修率和假体周围感染翻修率相关。
要点
- 含抗生素骨水泥使用率从2007年50.6%上升至2015年69.4%。
- 平均随访5年,含抗生素骨水泥组全因翻修率5.3% vs 普通骨水泥组6.7%(p=0.0009)。
- 含抗生素骨水泥组假体周围感染翻修率1.9% vs 普通骨水泥组2.6%(p=0.005)。
核心结论
- 在美国退伍军人健康管理局医院行初次全膝关节置换术时,含抗生素骨水泥的使用随时间增加,并与较低的全因翻修率和较低的假体周围感染翻修率相关。
研究设计与样本
- 回顾性识别2007至2015年在美国退伍军人健康管理局医院使用骨水泥行初次全膝关节置换术且随访至少2年的患者,最终研究队列为使用高黏度Palacos骨水泥(含或不含庆大霉素)者。
- 共纳入15,972例患者,其中普通骨水泥组4,741例,含抗生素骨水泥组11,231例。
- 主要结局为翻修全膝关节置换术,从退伍军人健康管理局和非退伍军人健康管理局医院识别全因翻修和因假体周围感染翻修。
- 进行未调整和调整回归分析以识别与翻修率增加相关的变量。
主要发现
- 含抗生素骨水泥使用率从2007年50.6%上升至2015年69.4%。
- 平均随访5年,含抗生素骨水泥组全因翻修率5.3% vs 普通骨水泥组6.7%(p=0.0009)。
- 含抗生素骨水泥组假体周围感染翻修率1.9% vs 普通骨水泥组2.6%(p=0.005)。
- 多变量回归中,与普通骨水泥相比,含抗生素骨水泥使用与较低的全因翻修风险相关(HR 0.79,95%CI 0.68至0.92;p=0.0019)。
- 每71例初次全膝关节置换术使用含抗生素骨水泥可避免1例翻修全膝关节置换术。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is controversial whether the use of antibiotic-laden bone cement (ALBC) in primary total knee arthroplasty (TKA) affects periprosthetic joint infection (PJI) or revision rates. The impact of ALBC on outcomes of primary TKA have not been previously investigated in U.S. veterans, to our knowledge. The purposes of this study were to quantify utilization of ALBC among U.S. veterans undergoing primary TKA and to determine if ALBC usage is associated with differences in revision TKA rates. METHODS: Patients who had TKA with cement from 2007 to 2015 at U.S. Veterans Health Administration (VHA) hospitals with at least 2 years of follow-up were retrospectively identified. Patients who received high-viscosity Palacos bone cement with or without gentamicin were selected as the final study cohort. Patient demographic and comorbidity data were collected. Revision TKA was the primary outcome. All-cause revisions and revisions for PJI were identified from both VHA and non-VHA hospitals. Unadjusted and adjusted regression analyses were performed to identify variables that were associated with increased revision rates. RESULTS: The study included 15,972 patients who had primary TKA with Palacos bone cement at VHA hospitals from 2007 to 2015. Plain bone cement was used for 4,741 patients and ALBC was used for 11,231 patients. Utilization of ALBC increased from 50.6% in 2007 to 69.4% in 2015. At a mean follow-up of 5 years, TKAs with ALBC had a lower all-cause revision rate than those with plain bone cement (5.3% versus 6.7%; p = 0.0009) and a lower rate of revision for PJI (1.9% versus 2.6%; p = 0.005). On multivariable regression, ALBC use was associated with a lower risk of all-cause revision compared with plain bone cement (hazard ratio [HR]: 0.79, 95% confidence interval [CI]: 0.68 to 0.92; p = 0.0019). Seventy-one primary TKAs needed to be implanted with ALBC to avoid 1 revision TKA. CONCLUSIONS: The utilization of ALBC for primary TKAs performed at VHA hospitals has increased over time and was associated with a lower all-cause revision rate and a lower rate of revision for PJI. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Bendich I, Zhang N, Barry JJ, et al. Antibiotic-Laden Bone Cement Use and Revision Risk After Primary Total Knee Arthroplasty in U.S. Veterans. J Bone Joint Surg Am. 2020. PMID: 32890041. doi:10.2106/JBJS.20.00102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。